The reduction of intraocular pressure to normal levels in patients with hormonal glaucoma is mostly a clinical cure. Hormonal glaucoma is a common secondary glaucoma, which is generally caused by the proliferation of trabecular meshwork mesenchymal tissues inside the eye triggered by systemic or topical use of hormonal drugs, resulting in an increase in the resistance to aqueous drainage. Patients will have elevated intraocular pressure, which can easily cause visual field defects and optic nerve atrophy. In patients with hormonal glaucoma, it is possible for the IOP to drop to normal after discontinuing the hormonal medication, leading to clinical cure. If the intraocular pressure cannot be reduced to normal simply by stopping hormonal drugs, patients need to use intraocular pressure-lowering eye drops or surgical treatments, such as carteolol hydrochloride eye drops, brimonidine tartrate eye drops, trabeculectomy and so on. In general, the patient’s intraocular pressure can be stabilized at the normal level, then the patient can reach the level of clinical cure. It is recommended that patients with hormonal glaucoma consult a doctor in time to assess their condition and follow the doctor’s instructions for treatment.